Tvardi Therapeutics, Inc. (TVRD) — Financial Flexibility Index
Tvardi Therapeutics, Inc. (TVRD) has a Financial Flexibility Index of -0.52x as of March 2026. Free cash flow of $-5.86 Million (operating CF $-5.86 Million minus capex $0.00) represents -1% of total liabilities ($11.31 Million). Check TVRD asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Tvardi Therapeutics, Inc. Financial Flexibility Index (2020–2025)
Historical Financial Flexibility Index trend for Tvardi Therapeutics, Inc. across 6 annual periods. See Tvardi Therapeutics, Inc. working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Tvardi Therapeutics, Inc. (2020–2025)
Year-by-year free cash flow to debt coverage for Tvardi Therapeutics, Inc.. For the full company profile including market capitalisation, see TVRD stock market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.11x | $-23.50 Million | $-23.50 Million | $11.13 Million | ▼ -70.8% |
| 2024 | -1.24x | $-59.87 Million | $-60.92 Million | $48.42 Million | ▼ -490.0% |
| 2023 | -0.21x | $-18.66 Million | $-21.04 Million | $89.06 Million | ▼ -6.0% |
| 2022 | -0.20x | $-17.82 Million | $-17.87 Million | $90.15 Million | ▲ +93.6% |
| 2021 | -3.07x | $-60.05 Million | $-60.09 Million | $19.53 Million | ▼ -1225.6% |
| 2020 | -0.23x | $-5.14 Million | $-5.49 Million | $22.16 Million | — |